English
How to make accessible for practice new diagnostic approaches created by science
09.00 HOW TO MAKE ACCESSIBLE FOR PRACTICE NEW DIAGNOSTIC APPROACHES CREATED BY SCIENCE
Seminars with WHO EXPERTS Chairman: Dr Yana I. Gurkovskaya & Dr Farkhad Shamilov, Petrovax
09.00 Influence of polyoxidonium (immune adjuvant) on primary tumor and bone marrow in breast cancer patients. Chairman: Dr Maria.E. Ilatovskaya
09.30 Perspectives of CTC and DTC HER2 detection for therapeutic targeting: questions and concerns.
10.00 Coffee break
Chairman: Prof Nikolay N.Tupitsyn, Moscow, Russia & Lubov Kuprova, Bioline
10.30 8-color Euroflow panels in MRD diagnosis in leukemias and lymphomas. Chairmen: Prof Piarvin A. Zeynalova, Prof Timur T. Valiev & Mobil Akhmedov 11.00 CD20 in B-cell lymphomas: diagnosis and treatment of MRD. Immunochemotherapy with rituximab for pediatric patients with 3-4 Burkitt lymphoma risk group. Timur Valiev, Moscow, Russia11.30 YOUNG SCIENTIST SELECTED ORAL PRESENTATIONS
11.30 Antigen expression heterogenicity used for MRD monitoring in B-lymphoblastic leukemia. Kateryna Vilchevska, Donetsk, Ukraine 11.40 Possibilities of overcoming drug resistance of blast cells in children with relapse of acute lymphoblastic leukemia. Natalia Batmanova, Moscow, Russia11.50 Hospicell, a subset of bone marrow stromal cell regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line. Nadia Benabou, Paris, France
12.00 Role of telomerase mutation on myelodysplastic syndrome and other haematopoietic disorders. Sushama Jose Shyam, Brno, Czech Republic12.10 Take home message.